blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Podcast recap: David Bumcrot on the untapped power of regulatory RNAs

In the latest episode of The Genetics Podcast, we had a captivating conversation with Dr. David Bumcrot, Chief Scientific Officer at CAMP4 Therapeutics. From he...
Continue reading

Podcast recap: Melissa Haendel on building a rare disease data ecosystem from ontology to equity

In a recent episode of The Genetics Podcast, Dr. Melissa Haendel, Director of Translational Informatics and Precision Health and Professor at the University of ...
Continue reading

Podcast recap: Huma Qamar on pioneering gene therapy for retinal disease

In a recent episode of The Genetics Podcast, Dr. Huma Qamar, Chief Medical Officer at Ocugen, shares her extraordinary journey from a small town in Pakistan to ...
Continue reading

Podcast recap: Frank Gentile on harnessing autophagy to treat neurodegenerative diseases

In a recent episode of The Genetics Podcast, we talked to Frank Gentile, Chief Executive Officer of Casma Therapeutics, to explore how autophagy could be a valu...
Continue reading

Smarter trials with AI: For engineers and data teams

Technological advances and biomedical breakthroughs have triggered a paradigm shift in precision medicine. Clinical research is currently at a turning point at ...
Continue reading

Personalized medicine for DMD: Genetics to treatment

Duchenne muscular dystrophy (DMD) is an inherited disorder that is characterized by progressive muscle degeneration, leading to loss of function and premature d...
Continue reading

Podcast recap: Andres Moreno-Estrada on mapping Latin America's genetic legacy and its future

On a recent episode of The Genetics Podcast, Patrick was joined by Andres Moreno-Estrada, population geneticist and head of the Human Evolutionary Genomics Lab ...
Continue reading

Insights from the GBA1 conference: A call for precision and inclusion

We recently attended the GBA1 conference in Montreal, which brought together researchers, clinicians, biotech leaders, and patient advocates to discuss cutting-...
Continue reading

How precision medicine is advancing myasthenia gravis treatment

Myasthenia gravis (MG) is a chronic neuromuscular disorder (NMD) that is characterized by muscle fatigue and weakness. It is considered a rare disease, affectin...
Continue reading

Podcast recap: Frank Gleeson on targeting muscle regeneration to tackle Duchenne muscular dystrophy

On a recent episode of The Genetics Podcast, Patrick spoke with Frank Gleeson, co-founder and CEO of Satellos Bioscience, a Canadian biotech pioneering a regene...
Continue reading